Item 2.02 - Results of Operations and Financial Condition: Illumina issued a press release on July 30, 2026 announcing financial results for the second quarter ended June 28, 2026 Item 9.01 - Financial Statements and Exhibits: The full text of the Company's press release is attached as Exhibit 99.1 Filing Date: July 30, 2026 (current report filed on the same date as the earliest event reported)…

Our analysis rates this filing BULLISH. This filing presents an exceptionally positive picture with no material concerns. Illumina delivered strong Q2 results (9.5% YoY growth, healthy margins) and significantly raised full-year guidance across all key metrics—revenue, organic growth, and earnings.…

Concern level: LOW (1.2/10).

Notable risk changes: Revenue guidance raised to $4.60-$4.64B (from $4.52-$4.62B) - positive revision of $80-120M; Organic revenue growth guidance increased to >5% (from 2-4%) - significant acceleration in underlying business momentum; Non-GAAP diluted EPS guidance raised to $5.30-$5.40 (from $5.15-$5.30) - $150-250M earnings upside.

The model predicts ILMN will underperform the S&P 500 by about 0.1% over 30 days (model confidence 85%). This is model analysis for research, not investment advice.